Skip to content
Clinical Trials – home

Prednisolone: An Overview for Patients

67 / 125
trials open to patients / all trials
24+
Countries

In short

Prednisolone, a widely used corticosteroid medication, has been the subject of numerous clinical trials aimed at evaluating its effectiveness and safety in treating various medical conditions. This article explores recent studies involving prednisolone, highlighting its applications in ophthalmology, inflammatory diseases, and other medical fields. We'll examine how researchers are comparing different formulations and dosages of prednisolone to optimize its therapeutic benefits while minimizing potential side effects.

Introduction

Prednisolone is a corticosteroid medication used to treat various inflammatory and autoimmune conditions. It belongs to a class of drugs known as glucocorticoids, which work by reducing inflammation in the body. Prednisolone is similar to cortisol, a hormone naturally produced by the adrenal glands.

Medical Uses

Prednisolone is prescribed for several medical conditions, including:

  • Asthma: It is used to treat acute exacerbations of asthma in children and adults.
  • COVID-19: Prednisolone has been studied as a treatment for patients with COVID-19 pneumonia requiring oxygen supplementation.
  • Inflammatory conditions: It may be used for various inflammatory and autoimmune disorders.
  • Cancer: Prednisolone is sometimes used in combination with other drugs to treat certain types of cancer, such as B-cell lymphomas.

Administration and Dosage

Prednisolone is typically administered orally in tablet form. The dosage and duration of treatment can vary depending on the condition being treated and the patient's response. For example:

  • For acute asthma exacerbations in children, a study compared a single dose of dexamethasone to multiple doses of prednisolone.
  • In a COVID-19 study, patients received 60 mg per day of prednisolone (40 mg in the morning and 20 mg in the evening) for 10 days.
  • For certain cancer treatments, prednisolone may be given in combination with other drugs, such as oxaliplatin.

It's crucial to follow your doctor's instructions carefully when taking prednisolone, as the dosage may need to be tapered off gradually to avoid withdrawal symptoms.

Effectiveness

Prednisolone has shown effectiveness in various conditions:

  • In asthma treatment, its effectiveness is being compared to dexamethasone for acute exacerbations.
  • For COVID-19, researchers are studying its effects on mortality rates in patients requiring oxygen therapy.
  • In cancer treatment, prednisolone combined with other drugs has shown promise in treating certain types of lymphoma.

Side Effects and Precautions

Like all medications, prednisolone can cause side effects. Common side effects may include:

  • Increased appetite and weight gain
  • Mood changes
  • Difficulty sleeping
  • Increased blood sugar levels
  • Weakened immune system

Long-term use of prednisolone may lead to more serious side effects, such as osteoporosis, diabetes, and adrenal suppression. Your doctor will monitor you closely for these potential complications.

Comparisons to Other Medications

Prednisolone is often compared to other corticosteroids:

  • Dexamethasone: Studies are comparing the effectiveness of prednisolone to dexamethasone in treating asthma exacerbations and COVID-19.
  • Other steroids: Prednisolone may be used as an alternative to other steroids depending on the specific condition and patient factors.

Ongoing Research

Several clinical trials are currently investigating the use of prednisolone:

  • Comparing prednisolone to dexamethasone for COVID-19 treatment
  • Evaluating its effectiveness in treating acute asthma exacerbations in children
  • Studying its use in combination with other drugs for cancer treatment

Frequently Asked Questions

How long does it take for prednisolone to work?

The time it takes for prednisolone to work can vary depending on the condition being treated. For acute conditions like asthma exacerbations, some improvement may be seen within hours to days. For chronic conditions, it may take several days to weeks to see the full effect.

Can I stop taking prednisolone suddenly?

No, you should not stop taking prednisolone suddenly, especially if you've been on it for more than a few weeks. Your doctor will provide a tapering schedule to gradually reduce the dose, which helps prevent withdrawal symptoms and allows your body to adjust.

Are there any foods or medications I should avoid while taking prednisolone?

You should avoid grapefruit and grapefruit juice as they can interact with prednisolone. Always inform your doctor about all medications, supplements, and herbal products you're taking, as some may interact with prednisolone. Your doctor may also recommend limiting salt intake and ensuring adequate calcium and vitamin D to help prevent side effects.

Summary

AspectDetails
Drug NamePrednisolone
Drug ClassCorticosteroid (Glucocorticoid)
Main UsesAsthma, COVID-19, inflammatory conditions, certain cancers
AdministrationOral (tablets)
Common Side EffectsWeight gain, mood changes, sleep disturbances, increased blood sugar
Ongoing ResearchCOVID-19 treatment, asthma exacerbations, cancer therapy

Glossary

  • Corticosteroid - A class of steroid hormones produced in the adrenal cortex or made synthetically, used to reduce inflammation and suppress the immune system.
  • Glucocorticoid - A type of corticosteroid that affects metabolism and has anti-inflammatory effects.
  • Exacerbation - A worsening or increase in severity of a disease or its symptoms.
  • Adrenal suppression - A condition where the adrenal glands do not produce adequate amounts of steroid hormones, particularly cortisol.

Questions people often ask

Conditions where Prednisolone is being studied

Each condition opens its own overview and trial list

Trials with Prednisolone

Recruiting trials first

See all 125 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).